Official UK procurement notice
NP35925 Cardiovascular & Respiratory Medicines
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)
What is being bought19 lots · detail below
Published requirement descriptionThis Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 42 bids on the busiest of 15 lots · 42 suppliers appointed
Lots and requirements (19)Procurement structure
19 lots · all with a published value · same evaluation weights on every lotLot #1Epoprostenol Powder and Solvent (pH 10.5) for Solution for Infusion VialsRenewalPublished value£100,000
Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #2Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion VialsAwardedRenewalPublished value£4,541,953
Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #3Epinephrine (Adrenaline) Pre-Filled SyringesAwardedRenewalPublished value£1,555,316
Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #4Epinephrine (Adrenaline) Auto Injector DevicesRenewalPublished value£813,471
Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #5Enoxaparin Sodium InjectionAwardedRenewalPublished value£15,288,661
Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #6Urokinase InjectionsRenewalPublished value£472,523
Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #7Isosorbide Mononitrate Modified-Release (M/R) Capsules and TabletsAwardedRenewalPublished value£191,878
Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #8Diltiazem Hydrochloride Modified-Release (M/R) Capsules and TabletsAwardedRenewalPublished value£119,355
Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #9Verapamil Hydrochloride Modified-Release (M/R) Capsules and TabletsAwardedRenewalPublished value£62,465
Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #10Nifedipine Modified-Release (M/R) Capsules and TabletsAwardedRenewalPublished value£136,569
Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #11Theophylline Modified-Release (M/R) Capsules and TabletsRenewalPublished value£32,341
Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #12Branded and Branded Generic InhalersAwardedRenewalPublished value£4,897,823
Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #13Iloprost MedicinesAwardedRenewalPublished value£1,572,128
Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #14Dalteparin InjectionsAwardedRenewalPublished value£17,380,231
Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.
Lot #15Tinzaparin Sodium InjectionsAwardedRenewalPublished value£836,630
Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a lot basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #16Icatibant Solution for InjectionAwardedRenewalPublished value£381,184
Supply of Icatibant Solution for Injection to NHS Scotland. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.
Lot #17Treprostinil InjectionAwardedRenewalPublished value£283,678
Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority intends awarding an unranked multi supplier framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.
Lot #18Direct Acting Oral Anticoagulants (DOACs)AwardedRenewalPublished value£12,053,015
Supply of Direct Acting Oral Anticoagulants (DOACs) to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.
Lot #19All Other Cardiovascular & Respiratory MedicinesAwardedRenewalPublished value£34,429,229
Supply of All Other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line will be treated as an individual Lot. The Authority intends awarding each product line to a single Framework Participant. Full details can be found within the ITT.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Logistics: 5%
- price: 95%
Published award criteria (2)
- Logistics: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL,PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent at the date of submission of the tender.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender, should be included in the Qualification Envelope of the ITT under the T…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP35925 Cardiovascular & Respiratory Medicines” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 21 Oct 2024, 14:00 BST
- Last source update
- 6 May 2025, 11:14 BST
- Award evaluation window
- 20 Nov 2024 – …
- FTS notice number
2025/S 000-019020- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04afa6Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a
minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which
the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the
Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the thirty six (36) month contract duration and the twenty four (24) month extension period of the framework agreement. (SC Ref:795893)
How it was run
Official notice- Appointment period ends
- 20 Nov 2024, 12:00 GMT
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 20 Nov 2024, 12:00 GMT
Timeline
20 Nov 2024 → 6 May 2025 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown20 Nov 2024, 12:00 GMT
- Bids opened20 Nov 2024, 12:00 GMT
- Notice published6 May 2025, 11:14 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete6 May 2025, 11:14 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast15 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Epinephrine (Adrenaline) Pre-Filled Syringes
- Signed
- 7 Apr 2025
- Value
- £1,575,630
- Status
- active
Tinzaparin Sodium Injections
- Signed
- 7 Apr 2025
- Value
- £848,290
- Status
- active
Icatibant Solution for Injection
- Signed
- 7 Apr 2025
- Value
- £170,315
- Status
- active
Treprostinil Injection
- Signed
- 7 Apr 2025
- Value
- £223,250
- Status
- active
Direct Acting Oral Anticoagulants (DOACs)
- Signed
- 7 Apr 2025
- Value
- £446,140
- Status
- active
All Other Cardiovascular & Respiratory Medicines
- Signed
- 7 Apr 2025
- Value
- £24,410,075
- Status
- active
Nifedipine Modified-Release (M/R) Capsules and Tablets
- Signed
- 7 Apr 2025
- Value
- £13,855
- Status
- active
Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials
- Signed
- 7 Apr 2025
- Value
- £10,789,555
- Status
- active
Enoxaparin Sodium Injection
- Signed
- 7 Apr 2025
- Value
- £9,947,020
- Status
- active
Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets
- Signed
- 7 Apr 2025
- Value
- £53,405
- Status
- active
Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets
- Signed
- 7 Apr 2025
- Value
- £81,720
- Status
- active
Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets
- Signed
- 7 Apr 2025
- Value
- £37,695
- Status
- active
Branded and Branded Generic Inhalers
- Signed
- 7 Apr 2025
- Value
- £2,961,460
- Status
- active
Iloprost Medicines
- Signed
- 7 Apr 2025
- Value
- £257,595
- Status
- active
Dalteparin Injections
- Signed
- 7 Apr 2025
- Value
- £30,489,875
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 2 · Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 3 · Epinephrine (Adrenaline) Pre-Filled Syringes | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 5 · Enoxaparin Sodium Injection | 4bids · 4 electronic · 4 from abroad | 0 | — | — |
| 7 · Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets | 5bids · 5 electronic · 5 from abroad | 0 | — | — |
| 8 · Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets | 4bids · 4 electronic · 4 from abroad | 0 | — | — |
| 9 · Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 10 · Nifedipine Modified-Release (M/R) Capsules and Tablets | 3bids · 3 electronic · 3 from abroad | 0 | — | — |
| 12 · Branded and Branded Generic Inhalers | 12bids · 12 electronic · 12 from abroad | 0 | — | — |
| 13 · Iloprost Medicines | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 14 · Dalteparin Injections | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 15 · Tinzaparin Sodium Injections | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 16 · Icatibant Solution for Injection | 6bids · 6 electronic · 6 from abroad | 0 | — | — |
| 17 · Treprostinil Injection | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 18 · Direct Acting Oral Anticoagulants (DOACs) | 11bids · 11 electronic · 11 from abroad | 0 | — | — |
| 19 · All Other Cardiovascular & Respiratory Medicines | 42bids · 42 electronic · 42 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Framework contractors & participating bidders
42 commercial parties on the notice- AccordFramework contractor
- Aguettant LtdFramework contractor
- AspireFramework contractor
- Aventis Pharma Ltd t/a SanofiFramework contractor
- Bowmed Ibisqus LimitedFramework contractor
- Bristol LaboratoriesFramework contractor
- CST Pharma LtdFramework contractor
- Celix Pharma Ltd.Framework contractor
- Chiesi LimitedFramework contractor
- Colonis Pharma LtdFramework contractor
Show 32 more suppliers
- Consilient Health LtdFramework contractor
- Day Lewis Medical LtdFramework contractor
- Dr Reddy's Laboratories (UK) LtdFramework contractor
- Focus Pharmaceuticals LtdFramework contractor
- Galvany PharmaFramework contractor
- Gennisium Pharma SASFramework contractor
- GlaxoSmithKlineFramework contractor
- Glenmark Pharmaceuticals Europe LtdFramework contractor
- Grindeks KalceksFramework contractor
- Hikma Pharmaceutical International LimitedFramework contractor
- Kent Pharmaceuticals LtdFramework contractor
- MSN LabsFramework contractor
- Macure Pharma ApsFramework contractor
- Martindale PharmaFramework contractor
- Mercury Pharmaceuticals LimitedFramework contractor
- Morningside Pharmaceuticals LimitedFramework contractor
- Northumbria Healthcare NHS Foundation TrustFramework contractor
- Perennial Pharma LtdFramework contractor
- Pfizer LimitedFramework contractor
- Ranbaxy (UK) LtdFramework contractor
- Rosemont Pharmaceuticals LtdFramework contractor
- STADA UK - Thornton & RossFramework contractor
- SandozFramework contractor
- Selective Supplies LtdFramework contractor
- Stirling Anglian PharmaceuticalsFramework contractor
- SyriMedFramework contractor
- Techdow Pharma England LtdFramework contractor
- Venipharm LTDFramework contractor
- Viatris UK Healthcare LtdFramework contractor
- Wockhardt UK LimitedFramework contractor
- Zentiva Pharma UK LtdFramework contractor
- hameln pharma ltdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.